| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |